These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30406480)

  • 1. Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Jara M; Dziodzio T; Malinowski M; Lüttgert K; Nikolov R; Ritschl PV; Öllinger R; Pratschke J; Stockmann M
    Dig Dis Sci; 2019 Feb; 64(2):576-584. PubMed ID: 30406480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.
    Giannini EG; Savarino V
    Dig Dis Sci; 2013 Oct; 58(10):3024-8. PubMed ID: 23817924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test.
    Jara M; Malinowski M; Lüttgert K; Schott E; Neuhaus P; Stockmann M
    Transpl Int; 2015 Jan; 28(1):52-8. PubMed ID: 25263095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
    Finkenstedt A; Dorn L; Edlinger M; Prokop W; Risch L; Griesmacher A; Graziadei I; Vogel W; Zoller H
    Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis.
    Dziodzio T; Öllinger R; Schöning W; Rothkäppel A; Nikolov R; Juraszek A; Ritschl PV; Stockmann M; Pratschke J; Jara M
    BMC Gastroenterol; 2020 Aug; 20(1):265. PubMed ID: 32787947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.
    Stravitz RT; Reuben A; Mizrahi M; Lalazar G; Brown K; Gordon SC; Ilan Y; Sanyal A
    J Hepatol; 2015 Dec; 63(6):1345-51. PubMed ID: 26220750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Biegus J; Zymliński R; Sokolski M; Siwołowski P; Gajewski P; Nawrocka-Millward S; Poniewierka E; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2016 Dec; 18(12):1518-1521. PubMed ID: 27709804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test.
    Malinowski M; Jara M; Lüttgert K; Orr J; Lock JF; Schott E; Stockmann M
    Dig Dis Sci; 2014 Dec; 59(12):2983-91. PubMed ID: 24993690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test.
    Lock JF; Kotobi AN; Malinowski M; Schulz A; Jara M; Neuhaus P; Stockmann M
    Ann Hepatol; 2013; 12(4):556-62. PubMed ID: 23813133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores?
    Radisavljevic MM; Bjelakovic GB; Nagorni AV; Stojanovic MP; Radojkovicn MD; Jovic JZ; Ignjatovic AM; Radisavljevic MM; Simonovic MM
    Med Princ Pract; 2017; 26(2):169-175. PubMed ID: 27676412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.
    Papatheodoridis GV; Cholongitas E; Dimitriadou E; Touloumi G; Sevastianos V; Archimandritis AJ
    World J Gastroenterol; 2005 May; 11(20):3099-104. PubMed ID: 15918197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.